India · Delayed Price · Currency is INR Medico Remedies Statistics
Total Valuation
Medico Remedies has a market cap or net worth of INR 2.91 billion. The enterprise value is 3.06 billion.
| Market Cap | 2.91B |
| Enterprise Value | 3.06B |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 82.98M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.55% |
| Shares Change (QoQ) | +1.75% |
| Owned by Insiders (%) | 71.38% |
| Owned by Institutions (%) | 1.20% |
| Float | 22.02M |
Valuation Ratios
The trailing PE ratio is 21.03.
| PE Ratio | 21.03 |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| PB Ratio | 3.85 |
| P/TBV Ratio | 3.85 |
| P/FCF Ratio | 209.84 |
| P/OCF Ratio | 49.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.31, with an EV/FCF ratio of 221.00.
| EV / Earnings | 22.15 |
| EV / Sales | 1.29 |
| EV / EBITDA | 17.31 |
| EV / EBIT | 21.17 |
| EV / FCF | 221.00 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.09 |
| Debt / FCF | 13.87 |
| Interest Coverage | 7.48 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.57% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.65% |
| Revenue Per Employee | 22.62M |
| Profits Per Employee | 1.32M |
| Employee Count | 105 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medico Remedies has paid 51.50 million in taxes.
| Income Tax | 51.50M |
| Effective Tax Rate | 27.16% |
Stock Price Statistics
The stock price has decreased by -10.51% in the last 52 weeks. The beta is 0.62, so Medico Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -10.51% |
| 50-Day Moving Average | 41.67 |
| 200-Day Moving Average | 44.07 |
| Relative Strength Index (RSI) | 33.25 |
| Average Volume (20 Days) | 428,643 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medico Remedies had revenue of INR 2.38 billion and earned 138.15 million in profits. Earnings per share was 1.66.
| Revenue | 2.38B |
| Gross Profit | 577.79M |
| Operating Income | 144.53M |
| Pretax Income | 189.65M |
| Net Income | 138.15M |
| EBITDA | 176.81M |
| EBIT | 144.53M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 37.51 million in cash and 192.04 million in debt, with a net cash position of -154.53 million.
| Cash & Cash Equivalents | 37.51M |
| Total Debt | 192.04M |
| Net Cash | -154.53M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 754.75M |
| Book Value Per Share | 9.15 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 58.74 million and capital expenditures -44.90 million, giving a free cash flow of 13.85 million.
| Operating Cash Flow | 58.74M |
| Capital Expenditures | -44.90M |
| Depreciation & Amortization | 32.28M |
| Net Borrowing | -5.50M |
| Free Cash Flow | 13.85M |
| FCF Per Share | n/a |
Margins
Gross margin is 24.33%, with operating and profit margins of 6.08% and 5.82%.
| Gross Margin | 24.33% |
| Operating Margin | 6.08% |
| Pretax Margin | 7.98% |
| Profit Margin | 5.82% |
| EBITDA Margin | 7.44% |
| EBIT Margin | 6.08% |
| FCF Margin | 0.67% |
Dividends & Yields
Medico Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.55% |
| Shareholder Yield | -0.55% |
| Earnings Yield | 4.76% |
| FCF Yield | 0.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 16, 2023. It was a forward split with a ratio of 5.
| Last Split Date | Mar 16, 2023 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |